Explainable Multimodal Prognostic Modeling Uncovers New Clinically Relevant Pathological Features in a Multi-Institutional Pancreatic Neuroendocrine Tumor Cohort
Although many patients with a well-differentiated pancreatic neuroendocrine tumor (PanNET) are cured after surgical resection, it is hard to predict outcome in these patients. Current prognostic assessment relies largely on Ki-67 proliferation index, tumor stage, and established adverse pathologic features, such as vas...